Disposal of Pharma Division

RNS Number : 1072T
Yule Catto & Co PLC
01 December 2011
 



 

1 December 2011

 

Yule Catto & Co plc

 

Disposal of Pharma Division

 

 

Yule Catto & Co plc ("Yule Catto" or the "Group"), the international producer of specialty chemicals, is pleased to announce the sale of its non-core Pharma Chemicals division, Uquifa, to Vivimed Labs, an emerging global player in pharma, with strong interests in Europe, for a total consideration of £35.0 million.

 

The proceeds comprise £28.6 million paid in cash and an unconditional payment of £6.4 million deferred for three years, covered by an irrevocable UK bank guarantee.  The proceeds will be used to pay down Group indebtedness.

 

Uquifa is a manufacturer of Active Pharmaceutical Ingredients and intermediates for the pharmaceutical industry. It operates three manufacturing sites, two in Spain and one in Mexico, employing a total of 390 people.  Mark Robbins, CEO of Uquifa, and a member of the Yule Catto executive management team, will transfer with the business.

 

The Pharma division reported an operating profit of £4.45 million in the year to 31 December 2010, and had net assets of £41.6 million (gross assets of £63.7 million), as at 30 June 2011.  The transaction is expected to have a slightly dilutive effect on the Group's earnings.

 

Adrian Whitfield, Chief Executive of Yule Catto, commented:

 

"I am delighted to be able to announce this disposal.  Following the PolymerLatex acquisition we completed earlier this year, this marks the final step in a long process of transforming Yule Catto into a substantial highly focussed Specialty Polymer business.  We are pleased we have been able to find a good home for our Pharma business and wish the new owners and our former employees every success."

 

- Ends -

 

Enquiries:

Yule Catto

Adrian Whitfield, Chief Executive                                           Tel: 01279 442791

David Blackwood, Group Finance Director

 

MHP Communications

Andrew Jaques / John Olsen / Ian Payne                              Tel: 020 3128 8100

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISFDSFMSFFSEIF

Companies

Synthomer (SYNT)
UK 100

Latest directors dealings